Sumihito Nobusawa

4.6k total citations · 2 hit papers
115 papers, 3.1k citations indexed

About

Sumihito Nobusawa is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Sumihito Nobusawa has authored 115 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Genetics, 48 papers in Molecular Biology and 32 papers in Neurology. Recurrent topics in Sumihito Nobusawa's work include Glioma Diagnosis and Treatment (69 papers), Chromatin Remodeling and Cancer (24 papers) and Neuroblastoma Research and Treatments (21 papers). Sumihito Nobusawa is often cited by papers focused on Glioma Diagnosis and Treatment (69 papers), Chromatin Remodeling and Cancer (24 papers) and Neuroblastoma Research and Treatments (21 papers). Sumihito Nobusawa collaborates with scholars based in Japan, United States and France. Sumihito Nobusawa's co-authors include Hiroko Ohgaki, Paul Kleihues, Takuya Watanabe, Hideaki Yokoo, Yoichi Nakazato, Junko Hirato, Hayato Ikota, Anne Vital, Atsushi Sasaki and Young Ho Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sumihito Nobusawa

108 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas

2009 742 citations Takuya Watanabe, Sumihito Nobusawa et al. American Journal Of Pathology profile →
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas

2009 529 citations Sumihito Nobusawa, Takuya Watanabe et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Sumihito Nobusawa

Since Specialization

Citations

This map shows the geographic impact of Sumihito Nobusawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumihito Nobusawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumihito Nobusawa more than expected).

Fields of papers citing papers by Sumihito Nobusawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumihito Nobusawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumihito Nobusawa. The network helps show where Sumihito Nobusawa may publish in the future.

Co-authorship network of co-authors of Sumihito Nobusawa

This figure shows the co-authorship network connecting the top 25 collaborators of Sumihito Nobusawa. A scholar is included among the top collaborators of Sumihito Nobusawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumihito Nobusawa. Sumihito Nobusawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Embryonal tumor with multilayered rosettes, DICER1‐mutated, showing histologically unique neuronal differentiation after chemoradiotherapy 2025 ·Neuropathology ·(unknown), Chikako Kiyotani, Kimikazu Matsumoto, Takako Yoshioka, Hideaki Yokoo, Junko Hirato, Sumihito Nobusawa	0
2	H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study 2025 ·SHILAP Revista de lepidopterología ·Hironori Goto, Souichi Suenobu, Yuhki Koga, Shunsuke Yamamoto, Kentaro Nakashima, (unknown), Daiichiro Hasegawa, Ikuya Usami, (unknown), Hiroshi Moritake, Sumihito Nobusawa, Keisuke Okuno, Koji Kawaguchi, (unknown), Hisashi Ishida, Yuko Cho, Haruto Nishida, Daisuke Tomizawa, Kenji Ihara, (unknown)	0
3	Keratin‐positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour 2023 ·Histopathology ·(unknown), Shintaro Iwata, Kaishi Satomi, Taisuke Mori, Sumihito Nobusawa, Toshiteru Nagashima, Yuko Matsushita, Yasushi Yatabe, (unknown), Akira Kawai, Akihiko Yoshida	3
4	High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma 2023 ·Cancers ·(unknown), Takehiko Yokobori, Sumihito Nobusawa, (unknown), Junko Hirato, (unknown), (unknown), (unknown), Akira Nishi, Makoto Suzuki, Sayaka Otake, (unknown), Ken Shirabe	2
5	A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment 2023 ·Brain Tumor Pathology ·(unknown), Tomonari Suzuki, Keisuke Ishizawa, Sumihito Nobusawa, Hideaki Yokoo, Ryo Nishikawa, Masanori Yasuda, Atsushi Sasaki	2
6	Analysis of clinicopathological features and NAB2-STAT6 fusion variants of meningeal solitary fibrous tumor with ectopic salivary gland components in the cerebellopontine angle 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Yuichi Yamada, Satoshi Nakata, (unknown), (unknown), Satoshi Tanikawa, Takayuki Kato, Nobukazu Komoribayashi, (unknown), (unknown), Naoki Okura, Shinya Tanaka, Yoshinao Oda, Junko Hirato, Hideaki Yokoo, Sumihito Nobusawa	6
7	Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence 2021 ·Brain Tumor Pathology ·(unknown), Kazuhiko Mishima, Atsushi Sasaki, (unknown), Mitsuaki Shirahata, Tomonari Suzuki, Sumihito Nobusawa, Ryo Nishikawa	2
8	Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features 2020 ·Brain Tumor Pathology ·Sho Tamai, Yoshiko Nakano, Masashi Kinoshita, Hemragul Sabit, Sumihito Nobusawa, Yasuhito Arai, Natsuko Hama, Yasushi Totoki, Tatsuhiro Shibata, Koichi Ichimura, Mitsutoshi Nakada	9
9	Fatal Postpartum Hemorrhage in Diffuse Midline Glioma with H3-K27M Mutation 2019 ·Case Reports in Obstetrics and Gynecology ·Takeshi Miyazaki, Masahiro Tsuji, (unknown), Toshiko Minamoto, Noriyoshi Ishikawa, Junko Hirato, Sumihito Nobusawa, Yasuhiko Akiyama	6
10	Gliosarcoma with primitive neuronal, chondroid, osteoid and ependymal elements 2018 ·Neuropathology ·Yuka Yoshida, Munenori Ide, (unknown), (unknown), Sumihito Nobusawa, Hayato Ikota, Hideaki Yokoo	3
11	A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor 2017 ·Brain Tumor Pathology ·Nobuaki Funata, Sumihito Nobusawa, Satoshi Nakata, Tatsuya Yamazaki, (unknown), (unknown), (unknown), Ryoji Yamada, Nobusada Shinoura, Yutaka Mine	6
12	Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas 2014 ·Journal of Neuro-Oncology ·Aya Suzuki, Sumihito Nobusawa, Atsushi Natsume, Hiromichi Suzuki, Young-Ho Kim, Hideaki Yokoo, Masaya Nagaishi, Hayato Ikota, (unknown), Toshihiko Wakabayashi, Hiroko Ohgaki, Yoichi Nakazato	7
13	A case of oligodendroglioma with prominent neuronal differentiation 2013 ·Human Pathology ·Takanori Hirose, Sumihito Nobusawa, Yoichi Nakazato, Atsushi Sasaki	10
14	Pulmonary hypertension with extensive calcification in small pulmonary vessels and alveolar capillary wall in a chronic hemodialysis patient 2013 ·Journal of Cardiology Cases ·Yoshiaki Ohyama, (unknown), Koji Kurosawa, Akihiko Nakano, Masashi Arai, Sumihito Nobusawa, Yoichi Nakazato, Masahiko Kurabayashi	2
15	Anaplastic ependymoma with ependymoblastic multilayered rosettes 2013 ·Human Pathology ·Sumihito Nobusawa, Aya Suzuki, Masaya Nagaishi, (unknown), Hayato Ikota, Hideaki Yokoo, Junko Hirato, Yoichi Nakazato	3
16	High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein 2011 ·Brain Tumor Pathology ·Hayato Ikota, Sumihito Nobusawa, Yuko Tanaka, Hideaki Yokoo, Yoichi Nakazato	16
17	Genetic Alterations in MicroRNAs in Medulloblastomas 2011 ·Brain Pathology ·Shengqing Lv, Young Ho Kim, Giulio Fiaschetti, Tarek Shalaby, Sumihito Nobusawa, Hui Yang, Zheng Zhou, Michael A. Grotzer, Hiroko Ohgaki	46
18	Molecular Classification of Low-Grade Diffuse Gliomas 2010 ·American Journal Of Pathology ·Young Ho Kim, Sumihito Nobusawa, Michel Mittelbronn, Werner Paulus, Benjamin Brokinkel, Kathy Keyvani, Ulrich Sure, Karsten H. Wrede, Yoichi Nakazato, Yuko Tanaka, Anne Vital, Luigi Mariani, Robert Stawski, Takuya Watanabe, Umberto De Girolami, Paul Kleihues, Hiroko Ohgaki	175
19	Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas 2010 ·Journal of Neuro-Oncology ·Manila Antonelli, Francesca Romana Buttarelli, Antonietta Arcella, Sumihito Nobusawa, Vittoria Donofrio, (unknown), Felice Giangaspero	58
20	IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas breakdown → 2009 ·Clinical Cancer Research ·Sumihito Nobusawa, Takuya Watanabe, Paul Kleihues, Hiroko Ohgaki	529

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact